miR-150 promotes the proliferation of gastric cancer and lung cancer cells through negative regulation of the pro-apoptotic gene early growth response factor 2 (EGR2) and by targeting p53, respectively, suggesting its pro-tumorigenic function [12, 14]. The gene discussed is EGR2; the disease is gastric cancer.